Interventional Medical Device Solutions
IMDS is a Netherlands-based, privately held medical device company that designs and manufactures microcatheters, guide extension catheters, and a trapping balloon for interventional cardiologists performing complex PCI procedures, selling directly to cath labs across 11 countries from its Roden manufacturing facility.
- Company typePrivate
- Founded-
- HeadquartersRoden, Netherlands
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Interventional Medical Device Solutions does
Interventional Medical Device Solutions (IMDS) is a Netherlands-based, privately held specialty medical device company that designs, develops, and manufactures interventional cardiology catheters used in percutaneous coronary intervention (PCI). The company focuses on complex and high-risk procedures, including CHIP (Complex High-Risk and Indicated Patients) and CTO (Chronic Total Occlusion) cases, and serves interventional cardiologists and cath labs. Its product portfolio is concentrated in three device families: microcatheters (NHanceIT, NHancer Pro X, ReCross, NHancer Rx, ShapeIT, Micro Rx), guide extension catheters (FlowGuide, Guidion Short, Guidion Hydro), and the TrapIT trapping balloon catheter. Differentiated design features include proprietary NDurance hydrophilic coatings, braid-reinforced shafts, metal-reinforced tips, dual-lumen over-the-wire architectures with multiple distal exit ports, perfusion openings for pressure dampening reduction, and tactile auto-stop mechanisms.
All manufacturing is performed in-house at the company's Roden, The Netherlands facility, enabling end-to-end quality control and a fast concept-to-product development cycle. Products are PFAS-Free certified and compatible with adjunct imaging modalities such as IVUS. The commercial model is direct hardware sales to healthcare institutions through regional sales teams; pricing is handled via quote-based procurement rather than public list pricing. Effective October 1, 2025, IMDS ended its distribution partnership with BIOTRONIK and transitioned to a fully independent direct sales organization covering France, BeNeLux, South Africa, the DACH region, Poland, the UK, Ireland, and the United States, supported by a customer portal at customers.imds.nl. R&D has been partially subsidized by co-funded grants from the European Union, the Dutch Ministry of Economic Affairs (EZ), and the Samenwerkingsverband Noord-Nederland (SNN) regional development agency. Leadership includes CEO Edwin Schulting and US President Jason Bottiglieri.
Interventional Medical Device Solutions firmographics
Firmographics- Name
- Interventional Medical Device Solutions
- Legal name
- IMDS (Interventional Medical Device Solutions)
- Website
- https://imds.nl
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- IMDS is a Netherlands-based, privately held medical device company that designs and manufactures microcatheters, guide extension catheters, and a trapping balloon for interventional cardiologists performing complex PCI procedures, selling directly to cath labs across 11 countries from its Roden manufacturing facility.
- Ownership category
- akta.pro rank
Interventional Medical Device Solutions industry classification
Industry- Product category
- Interventional Cardiology Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)
Keywords
Where Interventional Medical Device Solutions is headquartered
LocationHeadquarters
- HQ city
- Roden
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Interventional Medical Device Solutions business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Device Sales: IMDS manufactures and sells interventional cardiovascular medical devices including microcatheters and guide extension catheters for PCI procedures. All manufacturing is performed in-house at their Roden, Netherlands facility. Products are sold through direct sales channels following the transition from BIOTRONIK distribution in October 2025.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Interventional Medical Device Solutions product offering
Product offeringCore offering
IMDS develops, manufactures, and sells interventional coronary medical devices — primarily microcatheters and guide extension catheters — used in percutaneous coronary intervention (PCI) procedures, including complex CHIP CTO cases. All manufacturing is performed in-house at the company's Roden, The Netherlands facility, and products are sold direct to healthcare providers across Europe, South Africa, and the United States.
Product overview
IMDS offers a focused portfolio of vascular intervention coronary products for percutaneous coronary interventions (PCI), including guide extension catheters (FlowGuide, Guidion Short, Guidion Hydro), microcatheters (NHanceIT, NHancer Pro X, ReCross, NHancer Rx, ShapeIT, Micro Rx), and the TrapIT trapping balloon catheter. All products are designed for complex PCI and CHIP CTO procedures, with manufacturing performed in-house at their Roden, The Netherlands facility. The portfolio enables advanced treatment options through specialized catheter technologies including dual-lumen designs, rapid exchange systems, and hydrophilic coatings.
Differentiator
Problem solved
Functional benefit
Brands
- FlowGuide: Rapid Exchange Guide Extension with perfusion openings to reduce pressure dampening during PCI procedures
- NHanceIT
- ReCross
- NHancer Rx
- TrapIT
- ShapeIT
- Micro Rx
- Guidion Short
- Guidion Hydro
- NHancer Pro X
Products and services
- NHanceIT
- NHancer Pro X Single Lumen OTW Microcatheter with hydrophilic coating (NDurance), braid-reinforced shaft, and ultra-low profile tip for guidewire support and exchange in everyday PCI complexity.
- ReCross Dual Lumen OTW Microcatheter with two separate over-the-wire lumens and three distal exit ports, enabling 360-degree guidewire redirection and complex PCI techniques such as Antegrade Dual Access (ADA) and Subintimal Guidewire Redirection (SGR).
- NHancer Rx Dual Lumen Rx (Rapid Exchange) Microcatheter combining rapid exchange delivery lumen with OTW lumen for dual guidewire procedures; features proximal angulated side exit port, removable stylet, and the market's smallest profile for 6F trapping compatibility.
- TrapIT Trapping Balloon Catheter designed to trap wires within guiding catheters for efficient OTW catheter exchange, featuring a tactile auto-stop that prevents tip exit from the guiding catheter and guides correct insertion depth.
- FlowGuide Rapid Exchange Guide Extension Catheter with 9 small distal perfusion openings to reduce pressure dampening, a radiopaque soft tip for true distal end visibility, stainless steel reinforcement, and IVUS compatibility.
- ShapeIT Rapid Exchange Microcatheter with a 180-degree preshaped distal end (shapable in the distal two centimeters) and true 1:1 torque response for side branch access in bifurcation PCI procedures.
- Micro Rx Rapid Exchange Microcatheter with ultra-low profile tip for guidewire support and lesion entry/penetration; end stop design facilitates guide extension catheter insertion without microcatheter removal.
- Guidion Short Short Rapid Exchange Guide Extension Catheter with a 15 cm distal shaft, oval push rod design for optimal pushability, and OTW device exchange capability for improved support in complex PCI.
- Guidion Hydro Rapid Exchange Guide Extension Catheter with FlexZone and NDurance hydrophilic coating for advanced trackability, radiopaque soft tip for true distal end visibility, and coil-reinforced shaft for smooth device delivery.
Companies that use Interventional Medical Device Solutions
Customer profileSegments1 record
Ideal customer profiles1 record
Interventional Medical Device Solutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature11 records
Interventional Medical Device Solutions partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights6 records
Interventional Medical Device Solutions competitors and assessment
Company assessmentDirect peers
- Asahi Intecc: Japan-based global leader in guidewires and microcatheters for PCI, including specialty OTW and dual-lumen microcatheters that compete head-to-head with IMDS's NHanceIT, ReCross, and NHancer Rx lines.
- Teleflex: Through its Vascular Solutions subsidiary, Teleflex sells the GuideLiner guide extension catheter family — the most direct functional competitor to IMDS's FlowGuide, Guidion Short, and Guidion Hydro products.
- Merit Medical Systems: Public interventional device specialist that sells guide extension catheters and accessory products into the same interventional cardiology call point, making it a close functional and go-to-market peer to IMDS.
- Acrostak: Swiss specialty manufacturer focused on coronary intervention microcatheters and specialty balloon catheters, with a product profile and customer base that closely mirror IMDS's complex-PCI focus.
- Reflow Medical: US-based specialty interventional catheter developer focused on complex coronary and peripheral procedures, with a product scope and customer profile closely aligned to IMDS's complex-PCI microcatheter line.
Broad incumbents
- Boston Scientific: Major interventional cardiology incumbent offering the Guidezilla guide extension catheter and a broad coronary device portfolio; competes with IMDS in guide extension and adjacent complex-PCI categories.
- Abbott Vascular: Multi-billion-dollar interventional cardiology franchise including coronary guidewires, microcatheters, and guide extension products that overlap with IMDS's coronary portfolio across complex PCI.
- Medtronic: Global medtech incumbent with a large coronary intervention portfolio, including guide extensions and microcatheter-class devices used in the same CHIP/CTO procedures IMDS targets.
- Terumo: Japanese medical device major with a substantial interventional systems business, including coronary guidewires and microcatheters used in complex PCI workflows comparable to IMDS's specialty catheter portfolio.
Emerging players
- Penumbra: Vascular intervention company expanding from neurovascular into coronary and peripheral markets; competes in adjacent complex intervention procedures and shares the same specialist hospital call point as IMDS.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Interventional Medical Device Solutions social profiles
Digital presenceInterventional Medical Device Solutions compliance and trust
Trust signalCompliance1 record
Interventional Medical Device Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Interventional Medical Device Solutions leadership team
Management profileNumber of profiles
Profiles18 records
Interventional Medical Device Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Interventional Medical Device Solutions M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Interventional Medical Device Solutions
What does Interventional Medical Device Solutions do?
IMDS develops, manufactures, and sells interventional coronary medical devices — primarily microcatheters and guide extension catheters — used in percutaneous coronary intervention (PCI) procedures, including complex CHIP CTO cases. All manufacturing is performed in-house at the company's Roden, The Netherlands facility, and products are sold direct to healthcare providers across Europe, South Africa, and the United States.
Is Interventional Medical Device Solutions a public or private company?
Interventional Medical Device Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Interventional Medical Device Solutions founded?
Interventional Medical Device Solutions was founded in -1. It employs 51 to 100 people.
Where is Interventional Medical Device Solutions based?
Interventional Medical Device Solutions is headquartered in Roden, Netherlands, in the Europe region.
How does Interventional Medical Device Solutions make money?
One revenue line is on record: medical Device Sales.
Who are Interventional Medical Device Solutions's main competitors?
Direct peers on record are Asahi Intecc, Teleflex, Merit Medical Systems, Acrostak and Reflow Medical. Broad incumbents are Boston Scientific, Abbott Vascular, Medtronic and Terumo. Penumbra is listed as an emerging player.
Does Interventional Medical Device Solutions have an API?
No public API is recorded for Interventional Medical Device Solutions.
What industry is Interventional Medical Device Solutions in?
Interventional Medical Device Solutions's product category is Interventional Cardiology Medical Devices. Its primary akta.pro industry code is HLAHAFAA, Coronary Stents & Drug-Eluting Technologies. Its NAICS code is 339112 and its SIC code is 3841.